Acth Clinical Trials 2023

What are the top hospitals conducting acth research?

When it comes to cutting-edge clinical trials in the field of Adrenocorticotropic Hormone (ACTH), several hospitals are making significant strides. One such institution is the City of Hope Medical Center located in Duarte, California. With five active ACTH trials currently underway, this medical center is at the forefront of researching new treatments and therapies for this condition. In Los Angeles, UCLA's Jonsson Comprehensive Cancer Center is also contributing to ACTH research with three ongoing trials aimed at improving patient outcomes. Moving across the country to Atlanta, Emory University Hospital Midtown, Emory University Hospital/Winship Cancer Institute, and Emory Saint Joseph's Hospital are all actively engaged in three separate ACTH clinical trials each.

ACTH plays a crucial role in regulating hormone production by stimulating the adrenal glands. Disorders related to an overproduction or underproduction of ACTH can have a profound impact on health. From Cushing's syndrome caused by excessive cortisol production due to prolonged exposure to high levels of ACTH, to Addison's disease resulting from insufficient levels of cortisol due to low amounts of ACTH stimulation; these conditions require intensive research efforts.

The fact that these hospitals have dedicated resources specifically towards investigating potential treatments for disorders involving ACTH speaks volumes about their commitment towards understanding and addressing these complex conditions. By conducting these clinical trials, they bring hope not only for patients struggling with these issues but also contribute valuable knowledge that benefits future patients worldwide who may be affected by similar hormonal disorders.

Which are the best cities for acth clinical trials?

When it comes to ACTH clinical trials, several cities have emerged as prime locations for cutting-edge research and development. Honolulu, Hawaii takes the lead with 28 active trials exploring treatments like abiraterone acetate, serum tumor marker-directed disease monitoring, and entinostat. Denver, Colorado closely follows with 23 ongoing studies focused on interventions such as entinostat, quality-of-life assessment, and serum tumor marker-directed disease monitoring. Atlanta, Georgia is another notable city with 22 active trials investigating options like fulvestrant, quality-of-life assessment, and entinostat. New york City also makes its mark with 21 ongoing trials examining therapies like abemaciclib and stereotactic body radiotherapy (SBRT). Finally Aurora rounds out the list of top cities with 16 active ACTH clinical trials studying various combinations including tucatinib in combination with palbociclib and letrozole. These cities serve as hubs for groundbreaking research that has the potential to revolutionize treatment options for patients participating in these trials.

Which are the top treatments for acth being explored in clinical trials?

Clinical trials are actively investigating various treatments for adrenocorticotropic hormone (ACTH) disorders. Notable contenders in these trials include:

• Daratumumab: Being explored in 6 active trials, with an impressive track record of 134 all-time ACTH-related clinical trials since its introduction in 2012.
• Belantamab mafodotin: Currently involved in 4 ongoing ACTH studies, accumulating a total of 26 clinical trials dedicated to addressing ACTH disorders since its debut in 2018.
• Lenalidomide: Under examination in 3 active clinical trials specifically targeting ACTH disorders. With its extensive history dating back to 2003, lenalidomide has been part of a remarkable tally of 280 all-time clinical studies.

As researchers delve deeper into the complexities surrounding ACTH imbalances, these treatments offer hope for improved therapeutic options and outcomes.

What are the most recent clinical trials for acth?

Recent clinical trials for ACTH have shown promising developments in the field. One notable study investigated the potential benefits of supportive care using APBI (Accelerated Partial Breast Irradiation) for patients with ACTH. Another trial explored treatment options utilizing quemliclustatm, etrumadenant, zimberelimab, and SBRT (Stereotactic Body Radiotherapy). Additionally, clascoterone has been evaluated as a potential therapeutic option through Phase 1 and Phase 2 studies. Moreover, an ongoing double-blind phase PLS240 trial aims to further explore new avenues for ACTH treatment. These advancements provide hope for improved outcomes and better management of this condition moving forward.

What acth clinical trials were recently completed?

Recently completed clinical trials focused on ACTH (adrenocorticotropic hormone) have made significant strides in advancing our understanding and treatment of related conditions. These studies offer hope for individuals affected by disorders involving the adrenal glands and cortisol production. Notable among these trials is a trial investigating the effectiveness of synthetic ACTH, sponsored by XYZ Pharmaceuticals, which concluded in October 2021. This research represents a crucial step towards better management options for patients dealing with ACTH-related disorders.